A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis

This study has been completed.
Sponsor:
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00479427
First received: May 24, 2007
Last updated: July 22, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 22, 2009